These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 19099412)
1. Uroporphyrinogen III synthase mutations related to congenital erythropoietic porphyria identify a key helix for protein stability. Fortian A; Castaño D; Ortega G; Laín A; Pons M; Millet O Biochemistry; 2009 Jan; 48(2):454-61. PubMed ID: 19099412 [TBL] [Abstract][Full Text] [Related]
2. C73R is a hotspot mutation in the uroporphyrinogen III synthase gene in congenital erythropoietic porphyria. Frank J; Wang X; Lam HM; Aita VM; Jugert FK; Goerz G; Merk HF; Poh-Fitzpatrick MB; Christiano AM Ann Hum Genet; 1998 May; 62(Pt 3):225-30. PubMed ID: 9803266 [TBL] [Abstract][Full Text] [Related]
3. Tuning intracellular homeostasis of human uroporphyrinogen III synthase by enzyme engineering at a single hotspot of congenital erythropoietic porphyria. ben Bdira F; González E; Pluta P; Laín A; Sanz-Parra A; Falcon-Perez JM; Millet O Hum Mol Genet; 2014 Nov; 23(21):5805-13. PubMed ID: 24925316 [TBL] [Abstract][Full Text] [Related]
4. Structural, thermodynamic, and mechanistical studies in uroporphyrinogen III synthase: molecular basis of congenital erythropoietic porphyria. Fortian A; Castaño D; Gonzalez E; Laín A; Falcon-Perez JM; Millet O Adv Protein Chem Struct Biol; 2011; 83():43-74. PubMed ID: 21570665 [TBL] [Abstract][Full Text] [Related]
5. A systematic analysis of the mutations of the uroporphyrinogen III synthase gene in congenital erythropoietic porphyria. Fontanellas A; Bensidhoum M; Enriquez de Salamanca R; Moruno Tirado A; de Verneuil H; Ged C Eur J Hum Genet; 1996; 4(5):274-82. PubMed ID: 8946173 [TBL] [Abstract][Full Text] [Related]
12. Identification of two new mutations in congenital erythropoietic porphyria. Bensidhoum M; Ged C; Hombrados I; Moreau-Gaudry F; Hift RS; Meissner P; Sturrock ED; de Verneuil H Eur J Hum Genet; 1995; 3(2):102-7. PubMed ID: 7552139 [TBL] [Abstract][Full Text] [Related]
13. Congenital erythropoietic porphyria: mutation update and correlations between genotype and phenotype. Ged C; Moreau-Gaudry F; Richard E; Robert-Richard E; de Verneuil H Cell Mol Biol (Noisy-le-grand); 2009 Feb; 55(1):53-60. PubMed ID: 19268002 [TBL] [Abstract][Full Text] [Related]
14. A knock-in mouse model of congenital erythropoietic porphyria. Ged C; Mendez M; Robert E; Lalanne M; Lamrissi-Garcia I; Costet P; Daniel JY; Dubus P; Mazurier F; Moreau-Gaudry F; de Verneuil H Genomics; 2006 Jan; 87(1):84-92. PubMed ID: 16314073 [TBL] [Abstract][Full Text] [Related]
15. Novel point mutation in the uroporphyrinogen III synthase gene causes congenital erythropoietic porphyria of a Japanese family. Takamura N; Hombrados I; Tanigawa K; Namba H; Nagayama Y; de Verneuil H; Yamashita S Am J Med Genet; 1997 Jun; 70(3):299-302. PubMed ID: 9188670 [TBL] [Abstract][Full Text] [Related]
16. Compound heterozygosity for a premature termination codon and missense mutation in the exon 10 of the uroporphyrinogen III cosynthase gene causes a severe phenotype of congenital erythropoietic porphyria. Kang TW; Oh SW; Kim MR; Lee JS; Kim SC J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):470-1. PubMed ID: 18647208 [No Abstract] [Full Text] [Related]
17. A molecular study of congenital erythropoietic porphyria in cattle. Agerholm JS; Thulstrup PW; Bjerrum MJ; Bendixen C; Jørgensen CB; Fredholm M Anim Genet; 2012 Apr; 43(2):210-5. PubMed ID: 22404357 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic potential of proteasome inhibitors in congenital erythropoietic porphyria. Blouin JM; Duchartre Y; Costet P; Lalanne M; Ged C; Lain A; Millet O; de Verneuil H; Richard E Proc Natl Acad Sci U S A; 2013 Nov; 110(45):18238-43. PubMed ID: 24145442 [TBL] [Abstract][Full Text] [Related]
19. Study of the genotype-phenotype relationship in four cases of congenital erythropoietic porphyria. To-Figueras J; Badenas C; Mascaró JM; Madrigal I; Merino A; Bastida P; Lecha M; Herrero C Blood Cells Mol Dis; 2007; 38(3):242-6. PubMed ID: 17270473 [TBL] [Abstract][Full Text] [Related]
20. ALAS2 acts as a modifier gene in patients with congenital erythropoietic porphyria. To-Figueras J; Ducamp S; Clayton J; Badenas C; Delaby C; Ged C; Lyoumi S; Gouya L; de Verneuil H; Beaumont C; Ferreira GC; Deybach JC; Herrero C; Puy H Blood; 2011 Aug; 118(6):1443-51. PubMed ID: 21653323 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]